Authors


Katherine Taber, PhD, FANPA

Latest:

A Practical Update on Neuroimaging for Psychiatric Disorders

Which neuroimaging test for which psychiatric patient-and when? What to ask the neuroradiologist?


Kathleen F. Holton, PhD, MPH

Latest:

The Influence of Diet on ADHD

There is good emerging evidence that aspects of diet can indeed affect ADHD. Clinical recommendations here.


Kathleen Franco, MD

Latest:

Inflammation, Psychosis, and the Brain

When the solution to a clinical or scientific puzzle eludes us for more than a century, as with schizophrenia, we need new methods to examine the pathology. If we want to make an impact on the disease we must shift research paradigms and focus on the early detection, early intervention, and new avenues of treatment that address different symptoms of schizophrenia.


Kathleen M Carroll, MD

Latest:

The Brave New World of Behavioral Therapies for Alcohol Use Disorders

In addition to the approval of novel medications for alcohol use disorders, the past several years have been marked by an emphasis on development, standardization, and dissemination of new behavioral therapies, including computer-based interventions.


Kathleen M. Rospenda, PhD

Latest:

Sexual Harassment and Alcohol Use

Since the 1990s there has been an increase in research on sexual harassment and its mental health consequences. These researchers discuss the use of alcohol to self-medicate harassment-engendered distress and the need for greater attention to potential alcohol-related consequences of harassment experiences.


Kathleen Quinn, MD

Latest:

Child and Adolescent Clinical Psychopharmacology, 4th ed.

Each edition of this book, beginning with the first in 1991, has received much use while sitting on my office shelf. The editions have spanned the modern era of child psychopharmacology and, along with the works of S. P. Kutcher, have offered practical clinical guidance in choosing and monitoring medications in children and teenagers while also providing an overview of the literature that supports child psychopharmacology.


Kathleen T. Brady, MD, PhD

Latest:

Substance Abuse in Women: Does Gender Matter?

There has been a growing awareness in recent years of the importance of gender in medical treatment and research. While much past research in addiction focused on men, there is now recognition that biologic and psychosocial differences between men and women influence the prevalence, presentation, comorbidity, and treatment of substance use disorders.


Kathryn L. Humphreys, PhD, EdM

Latest:

ADHD and Substance Use: Current Evidence and Treatment Considerations

Because comorbid substance abuse is the rule rather than the exception in individuals with ADHD, accurate diagnosis, prognosis, and management of ADHD is challenging even for the most skilled practitioners.


Kathryn R. Cullen, MD

Latest:

Treatment of Non-Suicidal Self-Injurious Behavior in Adolescents

This CME article provides an understanding of the treatment modalities for the management of nonsuicidal self-injury (NSSI) in adolescents.


Kathy Coffman, MD

Latest:

Transplant Psychiatry: Issues for Clinicians

The role of transplant psychiatrists is to assess both transplant and donor candidates to determine capacity to consent to the surgery, recent stressors and coping skills, social supports and availability of caregivers, and whether there are psychological or substance abuse issues that would affect outcomes.


Kathy Stone

Latest:

A New Focus on Reducing Misdiagnoses

epilepsy, migraine, headache, Parkinson disease, parkinsonism


Kaustubh G. Joshi, MD

Latest:

The Role of Social Media in Private Practice

The challenges of using social media can be as numerous as the benefits.



Kavital Lohano, MD

Latest:

The Anxious Bipolar Patient

Treatment of anxiety can be a challenge, since the mainstay of treatment may adversely affect the course of bipolar disorder.


Kealoha Hooper

Latest:

Youth-Led Suicide Prevention in an Indigenous Rural Community

Suicide is a pervasive public health issue for adolescents in Hawaii. In response, a youth leadership model was initiated to empower young leaders in suicide prevention through evidence-based training, relationship building, and community awareness.


Keh-ming Lin, MD, MPH

Latest:

Cultural and Ethnic Issues in Psychopharmacology

This article aims to provide a glimpse of recent developments that are relevant to cultural and ethnic influences on psychopharmacological responses.


Keith Ablow, MD

Latest:

Telling the Truth in Fiction

An author discusses the similarities he has found between creating believable characters and stories and his work as a psychiatrist.


Keith G. Rasmussen, MD

Latest:

Contemporary ECT, Part 2: Mechanism of Action and Future Research Directions

Simply telling patients “we don’t know how ECT works” neglects our abundant knowledge of what this treatment does. The authors review biological actions of ECT and discuss future directions for research.


Keith L. Martin

Latest:

Successful Exit Planning for Physicians

Whether planned or unplanned, a physician's departure from your practice will definitely have an impact, so be prepared.


Kelly L. Cozza, MD

Latest:

The Role of Psychiatrists in HIV Prevention

Because over half of persons with HIV infection have a lifetime history of depression or bipolar disorder, psychiatrists are uniquely positioned to provide both preventive and therapeutic interventions to vulnerable patients.


Kelly T. Woyewodzic, MD

Latest:

Sexual Minority Identity Development

Sexual identity development is a complex, multidimensional, and often fluid process. One must consider cognitive, social, emotional, cultural, and familial complexities among other aspects of the individual’s experience to contextualize a narrative concerning sexual identity development.


Keming Gao, MD, PhD

Latest:

Mood Disorders in 3 Clinical Reports

Useful information about mood disorders in 3 key areas-bipolar disorder, comorbid ADHD and depression, and suicide risk.


Ken Masters, MD

Latest:

The Lost Birds of Wounded Knee

I remember as a child gathering wild greens with my Cherokee grandmothers, 2 generations of them, and hearing the lilt of spoken Cherokee. I can still see myself listening quietly in the corner of the room while others came to visit my great-grandmother, a respected traditional healer. We were poor. There is no other way to say it. My mother carried water from a well in the middle of the field, and I remember before going outside to play in the snow that we wrapped bread sacks around our feet to keep them dry. But as a child, while life was hard and even harsh at times, it felt safe and constant.


Ken Terry

Latest:

Trendspotter: Technology Must Prove Its Value

The challenge of new technology - as in the example of robot-assisted surgery - is that costly innovations often become the standard of care before there’s sufficient evidence to tell whether they add real value that justifies their expense.


Kenneth Certa, MD

Latest:

Mini Quiz: Behaviorally Compromised Patients

In the emergency department, how should patients with behavioral disturbances and especially those with illnesses such as dementia, TBI, autism spectrum disorder, and intellectual disability be managed? Take the quiz and learn more.


Kenneth D. Belzer, PhD

Latest:

Tools for Assessing Generalized Anxiety Disorder

Generalized anxiety disorder (GAD) is a chronic, impairing and highly comorbid psychiatric condition. A small but sufficient group of empirically supported instruments to assess the severity of GAD are now available.


Kenneth Duckworth, MD

Latest:

Awakenings with the New Antipsychotics

The explosion of neuroscience developments in this "Decade of the Brain" now provides people with schizophrenia a new generation of antipsychotic therapies. For many, these medications (e.g., clozapine [Clozaril], olanzapine [Zyprexa], risperidone [Risperdal], and quetiapine [Seroquel]) produce an improvement over their "old" antipsychotics in terms of side effects and, for some, clinical response. For a select few, however, these medications can produce dramatic improvement, akin to what Sacks (1990) termed an "awakening." These medications create exciting opportunities to use psychotherapy, group work and rehabilitation with a population historically relegated to back wards or triaged to "case management."


Kenneth J. Bender, PharmD, MA

Latest:

SAINT iTBS Protocol Shows Promise for Bipolar I Depression

A refined rTMS protocol, the Stanford Accelerated Intelligent Neuromodulation Therapy for major depressive disorder, shows promise in bipolar disorder.


Kenneth J. Ruggiero, PhD

Latest:

Rape-Related PTSD: Issues and Interventions

Rape is a crime that is defined as an unwanted sexual act that results in oral, vaginal, or anal penetration. Generally speaking, there are 2 major types of rape. Forcible rape involves unwanted sexual penetration obtained by the use of force or threat of force. Drug- or alcohol-facilitated rape occurs when the victim is passed out or highly intoxicated because of voluntary or involuntary consumption of alcohol or drugs. Rape can happen to boys and men as well as to girls and women but this article will focus primarily on women.


Kenneth J. Weiss, MD

Latest:

Assassins in London and Washington Force Changes in the Insanity Defense

Across the centuries, March has been an eventful month for the insanity defense on both sides of the Atlantic, and the McNaughten rule remains the prevalent standard to this day.

© 2024 MJH Life Sciences

All rights reserved.